{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:00:24Z","timestamp":1794344424595,"version":"4.9.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41581-019-0217-5","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T19:02:35Z","timestamp":1572030155000},"page":"750-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Molecular stratification of idiopathic nephrotic syndrome"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-4518","authenticated-orcid":false,"given":"Moin A.","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"217_CR1","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2215\/CJN.00380116","volume":"11","author":"TH Banh","year":"2016","unstructured":"Banh, T. H. et al. Ethnic differences in incidence and outcomes of childhood nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 11, 1760\u20131768 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"217_CR2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1523-1755.2005.00524.x","volume":"68","author":"JS Kim","year":"2005","unstructured":"Kim, J. S. et al. High incidence of initial and late steroid resistance in childhood nephrotic syndrome. Kidney Int. 68, 1275\u20131281 (2005).","journal-title":"Kidney Int."},{"key":"217_CR3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","volume":"91","author":"A Bierzynska","year":"2017","unstructured":"Bierzynska, A. et al. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int. 91, 937\u2013947 (2017).","journal-title":"Kidney Int."},{"key":"217_CR4","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/ndt\/gfu363","volume":"30","author":"MA Saleem","year":"2015","unstructured":"Saleem, M. A. One hundred ways to kill a podocyte. Nephrol. Dial. Transpl. 30, 1266\u20131271 (2015).","journal-title":"Nephrol. Dial. Transpl."},{"key":"217_CR5","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1681\/ASN.V371351","volume":"3","author":"W Hunte","year":"1993","unstructured":"Hunte, W., al-Ghraoui, F. & Cohen, R. J. Secondary syphilis and the nephrotic syndrome. J. Am. Soc. Nephrol. 3, 1351\u20131355 (1993).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archinte.1962.03620200038008","volume":"110","author":"CG Becker","year":"1962","unstructured":"Becker, C. G. et al. Nephrotic syndrome after contact with mercury. A report of five cases, three after the use of ammoniated mercury ointment. Arch. Intern. Med. 110, 178\u2013186 (1962).","journal-title":"Arch. Intern. Med."},{"key":"217_CR7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrneph.2016.147","volume":"12","author":"RJ Maas","year":"2016","unstructured":"Maas, R. J. et al. Minimal change disease and idiopathic FSGS: manifestations of the same disease. Nat. Rev. Nephrol. 12, 768\u2013776 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"217_CR8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1542\/peds.73.4.497","volume":"73","author":"Report of the International Study of Kidney Disease in Children","year":"1984","unstructured":"Report of the International Study of Kidney Disease in Children. Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years\u2019 observation. Pediatrics 73, 497\u2013501 (1984).","journal-title":"Pediatrics"},{"key":"217_CR9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2215\/CJN.05950809","volume":"4","author":"P Niaudet","year":"2009","unstructured":"Niaudet, P. Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 4, 1547\u20131548 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"217_CR10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli, M. et al. Minimal change disease. Clin. J. Am. Soc. Nephrol. 12, 332\u2013345 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"217_CR11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","volume":"43","author":"VD D\u2019Agati","year":"2004","unstructured":"D\u2019Agati, V. D. et al. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am. J. Kidney Dis. 43, 368\u2013382 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"217_CR12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2215\/CJN.06260614","volume":"10","author":"A Trautmann","year":"2015","unstructured":"Trautmann, A. et al. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin. J. Am. Soc. Nephrol. 10, 592\u2013600 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"217_CR13","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga, A., Sinha, A. & Moudgil, A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N. Engl. J. Med. 356, 2751\u20132752 (2007).","journal-title":"N. Engl. J. Med."},{"key":"217_CR14","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima, K. et al. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384, 1273\u20131281 (2014).","journal-title":"Lancet"},{"key":"217_CR15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ndt\/gfu267","volume":"30","author":"A Sinha","year":"2015","unstructured":"Sinha, A. et al. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome. Nephrol. Dial. Transpl. 30, 96\u2013106 (2015).","journal-title":"Nephrol. Dial. Transpl."},{"key":"217_CR16","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1681\/ASN.2018010091","volume":"29","author":"H Trachtman","year":"2018","unstructured":"Trachtman, H. et al. DUET: a phase 2 study evaluating the efficacy and safety of sparsentan in patients with FSGS. J. Am. Soc. Nephrol. 29, 2745\u20132754 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR17","volume":"1","author":"X Fan","year":"2016","unstructured":"Fan, X. et al. SLIT2\/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion. JCI Insight 1, e86934 (2016).","journal-title":"JCI Insight"},{"key":"217_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2011.151","volume":"8","author":"GI Welsh","year":"2012","unstructured":"Welsh, G. I. & Saleem, M. A. The podocyte cytoskeleton\u2013key to a functioning glomerulus in health and disease. Nat. Rev. Nephrol. 8, 14\u201321 (2012).","journal-title":"Nat. Rev. Nephrol."},{"key":"217_CR19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0092-8674(93)90515-R","volume":"74","author":"JA Kreidberg","year":"1993","unstructured":"Kreidberg, J. A. et al. WT-1 is required for early kidney development. Cell 74, 679\u2013691 (1993).","journal-title":"Cell"},{"key":"217_CR20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","volume":"1","author":"M Kestila","year":"1998","unstructured":"Kestila, M. et al. Positionally cloned gene for a novel glomerular protein\u2013nephrin\u2013is mutated in congenital nephrotic syndrome. Mol. Cell 1, 575\u2013582 (1998).","journal-title":"Mol. Cell"},{"key":"217_CR21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/path.2661","volume":"220","author":"GI Welsh","year":"2010","unstructured":"Welsh, G. I. & Saleem, M. A. Nephrin \u2014 signature molecule of the glomerular podocyte? J. Pathol. 220, 328\u2013337 (2010).","journal-title":"J. Pathol."},{"key":"217_CR22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0002-9440(10)61782-8","volume":"159","author":"M Simons","year":"2001","unstructured":"Simons, M. et al. Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am. J. Pathol. 159, 1069\u20131077 (2001).","journal-title":"Am. J. Pathol."},{"key":"217_CR23","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1172\/JCI200112849","volume":"108","author":"K Schwarz","year":"2001","unstructured":"Schwarz, K. et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J. Clin. Invest. 108, 1621\u20131629 (2001).","journal-title":"J. Clin. Invest."},{"key":"217_CR24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1523-1755.2004.00776.x","volume":"66","author":"S Weber","year":"2004","unstructured":"Weber, S. et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int. 66, 571\u2013579 (2004).","journal-title":"Kidney Int."},{"key":"217_CR25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1126\/science.286.5438.312","volume":"286","author":"NY Shih","year":"1999","unstructured":"Shih, N. Y. et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286, 312\u2013315 (1999).","journal-title":"Science"},{"key":"217_CR26","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1681\/ASN.2016040387","volume":"28","author":"A Bierzynska","year":"2017","unstructured":"Bierzynska, A. et al. MAGI2 mutations cause congenital nephrotic syndrome. J. Am. Soc. Nephrol. 28, 1614\u20131621 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR27","doi-asserted-by":"crossref","first-page":"20137","DOI":"10.1074\/jbc.M109.099481","volume":"285","author":"TJ van Duijn","year":"2010","unstructured":"van Duijn, T. J. et al. Rac1 recruits the adapter protein CMS\/CD2AP to cell-cell contacts. J. Biol. Chem. 285, 20137\u201320146 (2010).","journal-title":"J. Biol. Chem."},{"key":"217_CR28","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1128\/MCB.23.14.4917-4928.2003","volume":"23","author":"TB Huber","year":"2003","unstructured":"Huber, T. B. et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol. Cell. Biol. 23, 4917\u20134928 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"217_CR29","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/sj.ki.5002575","volume":"72","author":"S Akilesh","year":"2007","unstructured":"Akilesh, S., Koziell, A. & Shaw, A. S. Basic science meets clinical medicine: identification of a CD2AP-deficient patient. Kidney Int. 72, 1181\u20131183 (2007).","journal-title":"Kidney Int."},{"key":"217_CR30","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/ndt\/gfn712","volume":"24","author":"M Gigante","year":"2009","unstructured":"Gigante, M. et al. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol. Dial. Transpl. 24, 1858\u20131864 (2009).","journal-title":"Nephrol. Dial. Transpl."},{"key":"217_CR31","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1172\/JCI46458","volume":"121","author":"S Akilesh","year":"2011","unstructured":"Akilesh, S. et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J. Clin. Invest. 121, 4127\u20134137 (2011).","journal-title":"J. Clin. Invest."},{"key":"217_CR32","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1172\/JCI69134","volume":"123","author":"HY Gee","year":"2013","unstructured":"Gee, H. Y. et al. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J. Clin. Invest. 123, 3243\u20133253 (2013).","journal-title":"J. Clin. Invest."},{"key":"217_CR33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/path.4149","volume":"229","author":"JJ Harris","year":"2013","unstructured":"Harris, J. J. et al. Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1. J. Pathol. 229, 660\u2013671 (2013).","journal-title":"J. Pathol."},{"key":"217_CR34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ydbio.2008.01.022","volume":"316","author":"A Pozzi","year":"2008","unstructured":"Pozzi, A. et al. Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev. Biol. 316, 288\u2013301 (2008).","journal-title":"Dev. Biol."},{"key":"217_CR35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ydbio.2007.10.047","volume":"313","author":"K Kanasaki","year":"2008","unstructured":"Kanasaki, K. et al. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev. Biol. 313, 584\u2013593 (2008).","journal-title":"Dev. Biol."},{"key":"217_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","volume":"14","author":"C Wei","year":"2008","unstructured":"Wei, C. et al. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 14, 55\u201363 (2008).","journal-title":"Nat. Med."},{"key":"217_CR37","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei, C. et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 17, 952\u2013960 (2011).","journal-title":"Nat. Med."},{"key":"217_CR38","first-page":"135608","volume":"2013","author":"Y Lin","year":"2013","unstructured":"Lin, Y., Rao, J., Zha, X. & Xu, H. Angiopoietin-like 3 induces podocyte F-actin rearrangement through integrin alpha(V)beta(3)\/FAK\/PI3K pathway-mediated Rac1 activation. Biomed Res. Int. 2013, 135608 (2013).","journal-title":"Biomed Res. Int."},{"key":"217_CR39","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1172\/JCI69000","volume":"123","author":"S Ashraf","year":"2013","unstructured":"Ashraf, S. et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J. Clin. Invest. 123, 5179\u20135189 (2013).","journal-title":"J. Clin. Invest."},{"key":"217_CR40","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1172\/JCI45693","volume":"121","author":"SF Heeringa","year":"2011","unstructured":"Heeringa, S. F. et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Invest. 121, 2013\u20132024 (2011).","journal-title":"J. Clin. Invest."},{"key":"217_CR41","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1681\/ASN.2006080833","volume":"18","author":"F Diomedi-Camassei","year":"2007","unstructured":"Diomedi-Camassei, F. et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J. Am. Soc. Nephrol. 18, 2773\u20132780 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR42","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1086\/510023","volume":"79","author":"LC Lopez","year":"2006","unstructured":"Lopez, L. C. et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 79, 1125\u20131129 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"217_CR43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.3512","volume":"48","author":"DA Braun","year":"2016","unstructured":"Braun, D. A. et al. Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome. Nat. Genet. 48, 457\u2013465 (2016).","journal-title":"Nat. Genet."},{"key":"217_CR44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub, R. J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2, 556\u2013560 (1974).","journal-title":"Lancet"},{"key":"217_CR45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00041552-200401000-00002","volume":"13","author":"V Eremina","year":"2004","unstructured":"Eremina, V. & Quaggin, S. E. The role of VEGF-A in glomerular development and function. Curr. Opin. Nephrol. Hypertens. 13, 9\u201315 (2004).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"217_CR46","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1172\/JCI71195","volume":"124","author":"I Daehn","year":"2014","unstructured":"Daehn, I. et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J. Clin. Invest. 124, 1608\u20131621 (2014).","journal-title":"J. Clin. Invest."},{"key":"217_CR47","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina, V. et al. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129\u20131136 (2008).","journal-title":"N. Engl. J. Med."},{"key":"217_CR48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","volume":"111","author":"V Eremina","year":"2003","unstructured":"Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707\u2013716 (2003).","journal-title":"J. Clin. Invest."},{"key":"217_CR49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI86418","volume":"127","author":"LS Keir","year":"2017","unstructured":"Keir, L. S. et al. VEGF regulates local inhibitory complement proteins in the eye and kidney. J. Clin. Invest. 127, 199\u2013214 (2017).","journal-title":"J. Clin. Invest."},{"key":"217_CR50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.semnephrol.2015.02.004","volume":"35","author":"Z Guan","year":"2015","unstructured":"Guan, Z., VanBeusecum, J. P. & Inscho, E. W. Endothelin and the renal microcirculation. Semin. Nephrol. 35, 145\u2013155 (2015).","journal-title":"Semin. Nephrol."},{"key":"217_CR51","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1681\/ASN.2013020195","volume":"25","author":"O Lenoir","year":"2014","unstructured":"Lenoir, O. et al. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis. J. Am. Soc. Nephrol. 25, 1050\u20131062 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR52","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.bbadis.2010.03.012","volume":"1802","author":"M Barton","year":"2010","unstructured":"Barton, M. Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans. Biochim. Biophys. Acta 1802, 1203\u20131213 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"217_CR53","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.2337\/diabetes.54.11.3095","volume":"54","author":"RJ Coward","year":"2005","unstructured":"Coward, R. J. et al. The human glomerular podocyte is a novel target for insulin action. Diabetes 54, 3095\u20133102 (2005).","journal-title":"Diabetes"},{"key":"217_CR54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","volume":"12","author":"GI Welsh","year":"2010","unstructured":"Welsh, G. I. et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 12, 329\u2013340 (2010).","journal-title":"Cell Metab."},{"key":"217_CR55","first-page":"195","volume":"6","author":"LS Keir","year":"2012","unstructured":"Keir, L. S., Marks, S. D. & Kim, J. J. Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des. Dev. Ther. 6, 195\u2013208 (2012).","journal-title":"Drug Des. Dev. Ther."},{"key":"217_CR56","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/IAI.00679-08","volume":"77","author":"MA Psotka","year":"2009","unstructured":"Psotka, M. A. et al. Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect. Immun. 77, 959\u2013969 (2009).","journal-title":"Infect. Immun."},{"key":"217_CR57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","volume":"31","author":"JC Davin","year":"2016","unstructured":"Davin, J. C. The glomerular permeability factors in idiopathic nephrotic syndrome. Pediatr. Nephrol. 31, 207\u2013215 (2016).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR58","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00467-017-3793-2","volume":"33","author":"A Bierzynska","year":"2018","unstructured":"Bierzynska, A. & Saleem, M. A. Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances. Pediatr. Nephrol. 33, 2027\u20132035 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR59","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1056\/NEJMc1202500","volume":"366","author":"L Gallon","year":"2012","unstructured":"Gallon, L. et al. Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N. Engl. J. Med. 366, 1648\u20131649 (2012).","journal-title":"N. Engl. J. Med."},{"key":"217_CR60","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/ng1918","volume":"38","author":"B Hinkes","year":"2006","unstructured":"Hinkes, B. et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat. Genet. 38, 1397\u20131405 (2006).","journal-title":"Nat. Genet."},{"key":"217_CR61","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00431-010-1278-4","volume":"170","author":"AM Wasilewska","year":"2011","unstructured":"Wasilewska, A. M., Kuroczycka-Saniutycz, E. & Zoch-Zwierz, W. Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur. J. Pediatr. 170, 389\u2013391 (2011).","journal-title":"Eur. J. Pediatr."},{"key":"217_CR62","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.tp.0000262569.27890.64","volume":"83","author":"AM Kuusniemi","year":"2007","unstructured":"Kuusniemi, A. M. et al. Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type (NPHS1). Transplantation 83, 1316\u20131323 (2007).","journal-title":"Transplantation"},{"key":"217_CR63","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1681\/ASN.2009101046","volume":"21","author":"R Gbadegesin","year":"2010","unstructured":"Gbadegesin, R. et al. A new locus for familial FSGS on chromosome 2P. J. Am. Soc. Nephrol. 21, 1390\u20131397 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR64","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0272-6386(03)00364-0","volume":"41","author":"R Bertelli","year":"2003","unstructured":"Bertelli, R. et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am. J. Kidney Dis. 41, 1314\u20131321 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"217_CR65","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00467-003-1408-6","volume":"19","author":"H Billing","year":"2004","unstructured":"Billing, H. et al. NPHS2 mutation associated with recurrence of proteinuria after transplantation. Pediatr. Nephrol. 19, 561\u2013564 (2004).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-6143.2006.01605.x","volume":"7","author":"R Becker-Cohen","year":"2007","unstructured":"Becker-Cohen, R. et al. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am. J. Transpl. 7, 256\u2013260 (2007).","journal-title":"Am. J. Transpl."},{"key":"217_CR67","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s00467-006-0148-9","volume":"21","author":"B Hocker","year":"2006","unstructured":"Hocker, B. et al. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr. Nephrol. 21, 1476\u20131479 (2006).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR68","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.ASN.0000113552.59155.72","volume":"15","author":"RG Ruf","year":"2004","unstructured":"Ruf, R. G. et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J. Am. Soc. Nephrol. 15, 722\u2013732 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR69","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1523-1755.2004.938_9.x","volume":"66","author":"G Caridi","year":"2004","unstructured":"Caridi, G. et al. Heterozygous NPHS1 or NPHS2 mutations in responsive nephrotic syndrome and the multifactorial origin of proteinuria. Kidney Int. 66, 1715\u20131716 (2004).","journal-title":"Kidney Int."},{"key":"217_CR70","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-017-3819-9","volume":"33","author":"G Dorval","year":"2018","unstructured":"Dorval, G. et al. Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome. Pediatr. Nephrol. 33, 473\u2013483 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR71","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ajhg.2014.04.010","volume":"94","author":"HY Gee","year":"2014","unstructured":"Gee, H. Y. et al. Mutations in EMP2 cause childhood-onset nephrotic syndrome. Am. J. Hum. Genet. 94, 884\u2013890 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"217_CR72","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1172\/JCI79504","volume":"125","author":"HY Gee","year":"2015","unstructured":"Gee, H. Y. et al. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. J. Clin. Investig. 125, 2375\u20132384 (2015).","journal-title":"J. Clin. Investig."},{"key":"217_CR73","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","volume":"70","author":"CY Xing","year":"2006","unstructured":"Xing, C. Y. et al. Direct effects of dexamethasone on human podocytes. Kidney Int. 70, 1038\u20131045 (2006).","journal-title":"Kidney Int."},{"key":"217_CR74","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul, C. et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 14, 931\u2013938 (2008).","journal-title":"Nat. Med."},{"key":"217_CR75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2215\/CJN.07200712","volume":"8","author":"HJ McCarthy","year":"2013","unstructured":"McCarthy, H. J. et al. Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 8, 637\u2013648 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"217_CR76","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jmedgenet-2017-104811","volume":"54","author":"ES Sen","year":"2017","unstructured":"Sen, E. S. et al. Clinical genetic testing using a custom-designed steroid-resistant nephrotic syndrome gene panel: analysis and recommendations. J. Med. Genet. 54, 795\u2013804 (2017).","journal-title":"J. Med. Genet."},{"key":"217_CR77","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2014.14604","volume":"312","author":"H Lee","year":"2014","unstructured":"Lee, H. et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 312, 1880\u20131887 (2014).","journal-title":"JAMA"},{"key":"217_CR78","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","volume":"26","author":"CE Sadowski","year":"2015","unstructured":"Sadowski, C. E. et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1279\u20131289 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR79","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.kint.2018.07.024","volume":"94","author":"O Gribouval","year":"2018","unstructured":"Gribouval, O. et al. Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults. Kidney Int. 94, 1013\u20131022 (2018).","journal-title":"Kidney Int."},{"key":"217_CR80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2215\/CJN.08750718","volume":"14","author":"T Yao","year":"2019","unstructured":"Yao, T. et al. Integration of genetic testing and pathology for the diagnosis of adults with FSGS. Clin. J. Am. Soc. Nephrol. 14, 213\u2013223 (2019).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"217_CR81","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41581-018-0057-8","volume":"14","author":"KJ Robson","year":"2018","unstructured":"Robson, K. J. et al. HLA and kidney disease: from associations to mechanisms. Nat. Rev. Nephrol. 14, 636\u2013655 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"217_CR82","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1681\/ASN.2017080859","volume":"29","author":"XY Jia","year":"2018","unstructured":"Jia, X. Y. et al. Strong association of the HLA-DR\/DQ locus with childhood steroid-sensitive nephrotic syndrome in the Japanese population. J. Am. Soc. Nephrol. 29, 2189\u20132199 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR83","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1681\/ASN.2017111185","volume":"29","author":"H Debiec","year":"2018","unstructured":"Debiec, H. et al. Transethnic, genome-wide analysis reveals immune-related risk alleles and phenotypic correlates in pediatric steroid-sensitive nephrotic syndrome. J. Am. Soc. Nephrol. 29, 2000\u20132013 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00467-016-3513-3","volume":"32","author":"BD Crawford","year":"2017","unstructured":"Crawford, B. D. et al. Evaluating Mendelian nephrotic syndrome genes for evidence for risk alleles or oligogenicity that explain heritability. Pediatr. Nephrol. 32, 467\u2013476 (2017).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR85","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3389\/fimmu.2019.01669","volume":"10","author":"K Kienzl-Wagner","year":"2019","unstructured":"Kienzl-Wagner, K., Waldegger, S. & Schneeberger, S. Disease recurrence-the sword of Damocles in kidney transplantation for primary focal segmental glomerulosclerosis. Front. Immunol. 10, 1669 (2019).","journal-title":"Front. Immunol."},{"key":"217_CR86","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1681\/ASN.2013080852","volume":"25","author":"WY Ding","year":"2014","unstructured":"Ding, W. Y. et al. Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J. Am. Soc. Nephrol. 25, 1342\u20131348 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR87","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s13312-012-0220-4","volume":"49","author":"A Sinha","year":"2012","unstructured":"Sinha, A. et al. Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr. 49, 881\u2013887 (2012).","journal-title":"Indian Pediatr."},{"key":"217_CR88","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2215\/CJN.07370715","volume":"11","author":"AK Buscher","year":"2016","unstructured":"Buscher, A. K. et al. Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 11, 245\u2013253 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"217_CR89","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199604043341402","volume":"334","author":"VJ Savin","year":"1996","unstructured":"Savin, V. J. et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N. Engl. J. Med. 334, 878\u2013883 (1996).","journal-title":"N. Engl. J. Med."},{"key":"217_CR90","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.ASN.0000046960.57614.17","volume":"14","author":"D Cattran","year":"2003","unstructured":"Cattran, D. et al. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 14, 448\u2013453 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR91","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0272-6386(04)00943-6","volume":"44","author":"H Trachtman","year":"2004","unstructured":"Trachtman, H. et al. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome. Am. J. Kidney Dis. 44, 604\u2013610 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"217_CR92","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","volume":"13","author":"MA Saleem","year":"2002","unstructured":"Saleem, M. A. et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 13, 630\u2013638 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR93","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.kint.2018.10.030","volume":"95","author":"P Srivastava","year":"2019","unstructured":"Srivastava, P. et al. Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients. Kidney Int. 95, 708\u2013716 (2019).","journal-title":"Kidney Int."},{"key":"217_CR94","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00467-018-3995-2","volume":"33","author":"TM Kitzler","year":"2018","unstructured":"Kitzler, T. M. et al. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome. Pediatr. Nephrol. 33, 1741\u20131750 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR95","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00467-012-2163-3","volume":"27","author":"M Bitzan","year":"2012","unstructured":"Bitzan, M. et al. TNF alpha pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and beta 3 integrin activation. Pediatr. Nephrol. 27, 2217\u20132226 (2012).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR96","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2004030172","volume":"16","author":"RJ Coward","year":"2005","unstructured":"Coward, R. J. et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J. Am. Soc. Nephrol. 16, 629\u2013637 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR97","doi-asserted-by":"crossref","first-page":"F913","DOI":"10.1152\/ajprenal.00093.2019","volume":"317","author":"CJ May","year":"2019","unstructured":"May, C. J. et al. Human Th17 cells produce a soluble mediator that increases podocyte motility via signalling pathways which mimic PAR-1 activation. Am. J. Physiol. Renal Physiol. 317, F913\u2013F921 (2019).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"217_CR98","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu, C. C. et al. Abatacept in B7-1-positive proteinuric kidney disease. N. Engl. J. Med. 369, 2416\u20132423 (2013).","journal-title":"N. Engl. J. Med."},{"key":"217_CR99","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41581-018-0037-z","volume":"14","author":"R Novelli","year":"2018","unstructured":"Novelli, R., Benigni, A. & Remuzzi, G. The role of B7-1 in proteinuria of glomerular origin. Nat. Rev. Nephrol. 14, 589\u2013596 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"217_CR100","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.bbadis.2017.06.010","volume":"1863","author":"EY Kim","year":"2017","unstructured":"Kim, E. Y., Roshanravan, H. & Dryer, S. E. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors. Biochim. Biophys. Acta 1863, 2342\u20132354 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"217_CR101","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MJT.0b013e3182811aca","volume":"20","author":"C Morath","year":"2013","unstructured":"Morath, C. et al. Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am. J. Ther. 20, 226\u2013229 (2013).","journal-title":"Am. J. Ther."},{"key":"217_CR102","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1106215","volume":"308","author":"MP Winn","year":"2005","unstructured":"Winn, M. P. et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801\u20131804 (2005).","journal-title":"Science"},{"issue":"10","key":"217_CR103","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1681\/ASN.2018070729","volume":"30","author":"Louise K. Farmer","year":"2019","unstructured":"Farmer, L. K., et al. TRPC6 binds to and activates calpain, independent of its channel activity, and regulates podocyte cytoskeleton, cell adhesion, and motility. J. Am. Soc. Nephrol. https:\/\/doi.org\/10.1681\/ASN.2018070729 (2019).","journal-title":"Journal of the American Society of Nephrology"},{"key":"217_CR104","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1681\/ASN.2016111248","volume":"29","author":"KAT Verheijden","year":"2018","unstructured":"Verheijden, K. A. T. et al. The calcium-dependent protease calpain-1 links TRPC6 activity to podocyte injury. J. Am. Soc. Nephrol. 29, 2099\u20132109 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR105","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41591-018-0200-x","volume":"24","author":"G Veit","year":"2018","unstructured":"Veit, G. et al. Structure-guided combination therapy to potently improve the function of mutant CFTRs. Nat. Med. 24, 1732\u20131742 (2018).","journal-title":"Nat. Med."},{"key":"217_CR106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1600-0854.2003.00148.x","volume":"5","author":"S Roselli","year":"2004","unstructured":"Roselli, S. et al. Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations. Traffic 5, 37\u201344 (2004).","journal-title":"Traffic"},{"key":"217_CR107","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1089\/hum.2017.167","volume":"28","author":"AC Nathwani","year":"2017","unstructured":"Nathwani, A. C., Davidoff, A. M. & Tuddenham, E. G. D. Advances in gene therapy for hemophilia. Hum. Gene Ther. 28, 1004\u20131012 (2017).","journal-title":"Hum. Gene Ther."},{"key":"217_CR108","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"217_CR109","volume":"9","author":"LJ Hale","year":"2018","unstructured":"Hale, L. J. et al. 3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening. Nat. Commun. 9, 5167 (2018).","journal-title":"Nat. Commun."},{"key":"217_CR110","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature15695","volume":"526","author":"M Takasato","year":"2015","unstructured":"Takasato, M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564\u2013568 (2015).","journal-title":"Nature"},{"key":"217_CR111","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nbt.3392","volume":"33","author":"R Morizane","year":"2015","unstructured":"Morizane, R. et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 33, 1193\u20131200 (2015).","journal-title":"Nat. Biotechnol."},{"key":"217_CR112","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1681\/ASN.2015010096","volume":"27","author":"S Sharmin","year":"2016","unstructured":"Sharmin, S. et al. Human induced pluripotent stem cell-derived podocytes mature into vascularized glomeruli upon experimental transplantation. J. Am. Soc. Nephrol. 27, 1778\u20131791 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR113","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.stem.2017.10.011","volume":"21","author":"A Taguchi","year":"2017","unstructured":"Taguchi, A. & Nishinakamura, R. Higher-order kidney organogenesis from pluripotent stem cells. Cell Stem Cell 21, 730\u2013773 (2017).","journal-title":"Cell Stem Cell"},{"key":"217_CR114","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1681\/ASN.2015030316","volume":"27","author":"C Xinaris","year":"2016","unstructured":"Xinaris, C. et al. Functional human podocytes generated in organoids from amniotic fluid stem cells. J. Am. Soc. Nephrol. 27, 1400\u20131411 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR115","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrneph.2017.148","volume":"13","author":"ML Merchant","year":"2017","unstructured":"Merchant, M. L. et al. Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery. Nat. Rev. Nephrol. 13, 731\u2013749 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"217_CR116","first-page":"71","volume":"24","author":"ZW Lai","year":"2015","unstructured":"Lai, Z. W., Petrera, A. & Schilling, O. Protein amino-terminal modifications and proteomic approaches for N-terminal profiling. Curr. Opin. Chem. Biol. 24, 71\u201379 (2015).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"217_CR117","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbpa.2012.11.025","volume":"17","author":"PF Lange","year":"2013","unstructured":"Lange, P. F. & Overall, C. M. Protein TAILS: when termini tell tales of proteolysis and function. Curr. Opin. Chem. Biol. 17, 73\u201382 (2013).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"217_CR118","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd2092","volume":"5","author":"B Turk","year":"2006","unstructured":"Turk, B. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug Discov. 5, 785\u2013799 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"217_CR119","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.1405987111","volume":"111","author":"AP Wiita","year":"2014","unstructured":"Wiita, A. P. et al. Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling. Proc. Natl Acad. Sci. USA 111, 7594\u20137599 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"217_CR120","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ajpath.2011.01.017","volume":"178","author":"C Meyer-Schwesinger","year":"2011","unstructured":"Meyer-Schwesinger, C. et al. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy. Am. J. Pathol. 178, 2044\u20132057 (2011).","journal-title":"Am. J. Pathol."},{"key":"217_CR121","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41581-019-0148-1","volume":"15","author":"C Meyer-Schwesinger","year":"2019","unstructured":"Meyer-Schwesinger, C. The ubiquitin-proteasome system in kidney physiology and disease. Nat. Rev. Nephrol. 15, 393\u2013411 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"217_CR122","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.kint.2018.08.037","volume":"95","author":"MR Spath","year":"2019","unstructured":"Spath, M. R. et al. The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injury. Kidney Int. 95, 333\u2013349 (2019).","journal-title":"Kidney Int."},{"key":"217_CR123","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrneph.2017.98","volume":"13","author":"D Karpman","year":"2017","unstructured":"Karpman, D., Stahl, A. L. & Arvidsson, I. Extracellular vesicles in renal disease. Nat. Rev. Nephrol. 13, 545\u2013562 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"217_CR124","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ki.2013.422","volume":"85","author":"MC Hogan","year":"2014","unstructured":"Hogan, M. C. et al. Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine. Kidney Int. 85, 1225\u20131237 (2014).","journal-title":"Kidney Int."},{"key":"217_CR125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-015-3239-7","volume":"31","author":"E Erkan","year":"2016","unstructured":"Erkan, E. et al. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis. Pediatr. Nephrol. 31, 581\u2013588 (2016).","journal-title":"Pediatr. Nephrol."},{"issue":"11","key":"217_CR126","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00467-019-04296-6","volume":"34","author":"Lokesh Shah","year":"2019","unstructured":"Shah, L., et al. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients. Pediatr. Nephrol. https:\/\/doi.org\/10.1007\/s00467-019-04296-6 (2019).","journal-title":"Pediatric Nephrology"},{"key":"217_CR127","doi-asserted-by":"crossref","DOI":"10.1186\/s12014-016-9126-9","volume":"13","author":"M Kaisar","year":"2016","unstructured":"Kaisar, M. et al. Plasma degradome affected by variable storage of human blood. Clin. Proteom. 13, 26 (2016).","journal-title":"Clin. Proteom."},{"key":"217_CR128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fped.2018.00200","volume":"6","author":"A Trautmann","year":"2018","unstructured":"Trautmann, A., Lipska-Zietkiewicz, B. S. & Schaefer, F. Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: the PodoNet Registry. Front. Pediatr. 6, 200 (2018).","journal-title":"Front. Pediatr."},{"key":"217_CR129","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","volume":"83","author":"CA Gadegbeku","year":"2013","unstructured":"Gadegbeku, C. A. et al. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int. 83, 749\u2013756 (2013).","journal-title":"Kidney Int."},{"key":"217_CR130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00467-018-4149-2","volume":"34","author":"C Dossier","year":"2019","unstructured":"Dossier, C. et al. Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study. Pediatr. Nephrol. 34, 671\u2013678 (2019).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR131","first-page":"96","volume":"2014","author":"E Scheufele","year":"2014","unstructured":"Scheufele, E. et al. tranSMART: an open source knowledge management and high content data analytics platform. AMIA Jt. Summits Transl. Sci. Proc. 2014, 96\u2013101 (2014).","journal-title":"AMIA Jt. Summits Transl. Sci. Proc."},{"key":"217_CR132","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/archdischild-2018-315125","volume":"104","author":"WY Ding","year":"2019","unstructured":"Ding, W. Y. et al. Big data and stratified medicine: what does it mean for children? Arch. Dis. Child. 104, 389\u2013394 (2019).","journal-title":"Arch. Dis. Child."},{"key":"217_CR133","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551\u2013565 (2016).","journal-title":"Cell"},{"key":"217_CR134","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2202\/1544-6115.1441","volume":"8","author":"P Agius","year":"2009","unstructured":"Agius, P., Ying, Y. & Campbell, C. Bayesian unsupervised learning with multiple data types. Stat. Appl. Genet. Mol. Biol. 8, 27 (2009).","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"217_CR135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","journal-title":"Nature"},{"key":"217_CR136","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12882-017-0452-6","volume":"18","author":"V Perez","year":"2017","unstructured":"Perez, V. et al. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis. BMC Nephrol. 18, 49 (2017).","journal-title":"BMC Nephrol."},{"key":"217_CR137","volume":"14","author":"YW Choi","year":"2017","unstructured":"Choi, Y. W. et al. Potential urine proteomics biomarkers for primary nephrotic syndrome. Clin. Proteom. 14, 18 (2017).","journal-title":"Clin. Proteom."},{"key":"217_CR138","first-page":"7298160","volume":"2017","author":"Z Huang","year":"2017","unstructured":"Huang, Z., Zhang, Y., Zhou, J. & Zhang, Y. Urinary exosomal miR-193a can be a potential biomarker for the diagnosis of primary focal segmental glomerulosclerosis in children. Biomed. Res. Int. 2017, 7298160 (2017).","journal-title":"Biomed. Res. Int."},{"key":"217_CR139","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/eci.12420","volume":"45","author":"A Ramezani","year":"2015","unstructured":"Ramezani, A. et al. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study. Eur. J. Clin. Invest. 45, 394\u2013404 (2015).","journal-title":"Eur. J. Clin. Invest."},{"key":"217_CR140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chroma.2016.05.058","volume":"1453","author":"JE Lee","year":"2016","unstructured":"Lee, J. E. et al. Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography-mass spectrometry. J. Chromatogr. A 1453, 105\u2013115 (2016).","journal-title":"J. Chromatogr. A"},{"key":"217_CR141","first-page":"371","volume":"8","author":"W Sui","year":"2014","unstructured":"Sui, W. et al. Circulating microRNAs as potential biomarkers for nephrotic syndrome. Iran. J. Kidney Dis. 8, 371\u2013376 (2014).","journal-title":"Iran. J. Kidney Dis."},{"key":"217_CR142","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.yexmp.2015.10.003","volume":"99","author":"M Lu","year":"2015","unstructured":"Lu, M. et al. Differentially expressed microRNAs in kidney biopsies from various subtypes of nephrotic\u00a0children. Exp. Mol. Pathol. 99, 590\u2013595 (2015).","journal-title":"Exp. Mol. Pathol."},{"key":"217_CR143","doi-asserted-by":"crossref","first-page":"574261","DOI":"10.1155\/2014\/574261","volume":"2014","author":"M Nafar","year":"2014","unstructured":"Nafar, M. et al. The novel diagnostic biomarkers for focal segmental glomerulosclerosis. Int. J. Nephrol. 2014, 574261 (2014).","journal-title":"Int. J. Nephrol."},{"key":"217_CR144","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4103\/1319-2442.182393","volume":"27","author":"P Pant","year":"2016","unstructured":"Pant, P. et al. Serum sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of patients with membranous nephropathy and focal and segmental glomerulosclerosis. Saudi J. Kidney Dis. Transpl. 27, 539\u2013545 (2016).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"217_CR145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10157-015-1162-7","volume":"20","author":"CP Suresh","year":"2016","unstructured":"Suresh, C. P. et al. Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome. Clin. Exp. Nephrol. 20, 273\u2013283 (2016).","journal-title":"Clin. Exp. Nephrol."},{"key":"217_CR146","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2369-15-141","volume":"15","author":"S Kalantari","year":"2014","unstructured":"Kalantari, S. et al. Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis. BMC Nephrol. 15, 141 (2014).","journal-title":"BMC Nephrol."},{"key":"217_CR147","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12098-015-1809-0","volume":"83","author":"A Nickavar","year":"2016","unstructured":"Nickavar, A. et al. Urine neutrophil gelatinase associated lipocalin to creatinine ratio: a novel index for steroid response in idiopathic nephrotic syndrome. Indian J. Pediatr. 83, 18\u201321 (2016).","journal-title":"Indian J. Pediatr."},{"key":"217_CR148","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/1319-2442.174066","volume":"27","author":"N Gopal","year":"2016","unstructured":"Gopal, N. et al. Assay of urinary protein-bound sialic acid can differentiate steroidsensitive nephrotic syndrome from steroid-resistant cases. Saudi J. Kidney Dis. Transpl. 27, 37\u201340 (2016).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"217_CR149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/BMI.S31633","volume":"11","author":"MR Bennett","year":"2016","unstructured":"Bennett, M. R. et al. Urinary vitamin D-binding protein as a biomarker of steroid-resistant nephrotic syndrome. Biomark. Insights 11, 1\u20136 (2016).","journal-title":"Biomark. Insights"},{"key":"217_CR150","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s12098-016-2142-y","volume":"83","author":"HS Badr","year":"2016","unstructured":"Badr, H. S., El-Hawy, M. A. & Helwa, M. A. P-glycoprotein activity in steroid-responsive vs. steroid-resistant nephrotic syndrome. Indian J. Pediatr. 83, 1222\u20131226 (2016).","journal-title":"Indian J. Pediatr."},{"key":"217_CR151","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2217\/pgs-2016-0029","volume":"17","author":"S Turolo","year":"2016","unstructured":"Turolo, S. et al. SXR rs3842689: a prognostic factor for steroid sensitivity or resistance in pediatric idiopathic nephrotic syndrome. Pharmacogenomics 17, 1227\u20131233 (2016).","journal-title":"Pharmacogenomics"},{"key":"217_CR152","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00467-017-3613-8","volume":"32","author":"OP Mishra","year":"2017","unstructured":"Mishra, O. P. et al. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome. Pediatr. Nephrol. 32, 1355\u20131361 (2017).","journal-title":"Pediatr. Nephrol."},{"key":"217_CR153","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/1319-2442.202764","volume":"28","author":"N Gopal","year":"2017","unstructured":"Gopal, N. et al. Assay of urinary protein carbonyl content can predict the steroid dependence and resistance in children with idiopathic nephrotic syndrome. Saudi J. Kidney Dis. Transpl. 28, 268\u2013272 (2017).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"217_CR154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1177271917695832","volume":"12","author":"MR Bennett","year":"2017","unstructured":"Bennett, M. R. et al. A novel biomarker panel to identify steroid resistance in childhood idiopathic nephrotic syndrome. Biomark. Insights 12, 1\u201311 (2017).","journal-title":"Biomark. Insights"},{"key":"217_CR155","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41431-018-0182-7","volume":"26","author":"MM Watany","year":"2018","unstructured":"Watany, M. M. & El-Horany, H. E. Nephronectin (NPNT) and the prediction of nephrotic syndrome response to steroid treatment. Eur. J. Hum. Genet. 26, 1354\u20131360 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"217_CR156","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/prca.201100081","volume":"6","author":"RF Andersen","year":"2012","unstructured":"Andersen, R. F. et al. Plasma and urine proteomic profiles in childhood idiopathic nephrotic syndrome. Proteom. Clin. Appl. 6, 382\u2013393 (2012).","journal-title":"Proteom. Clin. Appl."},{"key":"217_CR157","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2215\/CJN.11941115","volume":"11","author":"CY Chan","year":"2016","unstructured":"Chan, C. Y. et al. T lymphocyte activation markers as predictors of responsiveness to rituximab among patients with FSGS. Clin. J. Am. Soc. Nephrol. 11, 1360\u20131368 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"217_CR158","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/1744-9987.12356","volume":"20","author":"E Kuribayashi-Okuma","year":"2016","unstructured":"Kuribayashi-Okuma, E. et al. Proteomics approach identifies factors associated with the response to low-density lipoprotein apheresis therapy in patients with steroid-resistant nephrotic syndrome. Ther. Apher. Dial. 20, 174\u2013182 (2016).","journal-title":"Ther. Apher. Dial."},{"key":"217_CR159","doi-asserted-by":"crossref","DOI":"10.5812\/numonthly.16806","volume":"6","author":"S Kalantari","year":"2014","unstructured":"Kalantari, S. et al. Urinary prognostic biomarkers in patients with focal segmental glomerulosclerosis. Nephrourol. Mon. 6, e16806 (2014).","journal-title":"Nephrourol. Mon."},{"key":"217_CR160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1600-6143.2012.04338.x","volume":"13","author":"J Lopez-Hellin","year":"2013","unstructured":"Lopez-Hellin, J. et al. A form of apolipoprotein a-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation. Am. J. Transpl. 13, 493\u2013500 (2013).","journal-title":"Am. J. Transpl."},{"key":"217_CR161","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/tri.13372","volume":"32","author":"N Puig-Gay","year":"2019","unstructured":"Puig-Gay, N. et al. Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value \u2013 a multi-centre cohort study. Transpl. Int. 32, 313\u2013322 (2019).","journal-title":"Transpl. Int."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41581-019-0217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41581-019-0217-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41581-019-0217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:08:53Z","timestamp":1684620533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-019-0217-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":161,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1038\/s41581-019-0217-5","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"20 September 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}